Nav: Home

ACP: Not all patients need imaging for suspected PE

September 28, 2015

1. ACP: Doctors should stratify patients with suspected pulmonary embolism to determine diagnostic strategy

Overuse of computed tomography and D-dimer testing may not improve care and lead to patient harm and unnecessary expense
Free policy paper:
URL goes live when the embargo lifts

When evaluating patients with suspected acute pulmonary embolism (PE), physicians should stratify patients into groups for whom different diagnostic strategies are appropriate, the American College of Physicians (ACP) advises in a new paper published today in Annals of Internal Medicine.

PE is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung. Computed tomography (CT) is increasingly used to evaluate patients with suspected PE. However, there is no evidence to suggest that CT improves outcomes in such patients, and its use is associated with risks and expense. ACP's advice is designed to help physicians identify patients for whom testing, including imaging, is needed and for whom it is not.

In patients who have a low pre-test probability of PE, physicians should apply the PERC (Pulmonary Embolism Rule-Out Criteria) rule. Physicians should not obtain D-dimer tests or imaging studies in patients with a low pre-test probability of PE and who meet all eight PERC. Patients who have an intermediate pre-test probability of PE or patients with low pre-test probability of PE who do not meet all PERC should have a high sensitivity D-dimer test as the initial step in diagnosis, but no imaging. Patients with high pre-test probability of PE should obtain imaging with CT pulmonary angiography. Physicians should reserve V/Q scans for patients who have a contraindication for CT pulmonary angiography or if CT pulmonary angiography is not available. Physicians should avoid obtaining a D-dimer measurement in patients with a high pre-test probability of PE.

Note: For an embargoed PDF, please contact Angela Collom. To speak with someone from the American College of Physicians, please contact Steve Majewski at or 215-351-2514.

2. U.S. cervical cancer screening practices show room for improvement
URL goes live when the embargo lifts

An analysis published in Annals of Internal Medicine shows that current U.S. cervical cancer screening practices are inefficient with respect to health benefits and costs, due to noncompliance with recommended guidelines. Additional investments in interventions may be needed to improve screening programs.

Cytology-based screening has led to substantial declines in cervical cancer incidence and mortality, yet screening practices vary widely. Inefficiencies in screening lead to increased economic burden and disease incidence, especially among underserved populations. Researchers created mathematical models to compare reductions in lifetime cervical cancer risks, quality-adjusted life-years, and costs using current cervical cancer screening practices to the same outcomes using guideline-based screening intervals (every 3 years), HPV triage testing, diagnostic referrals, and precancer treatment referrals.

In terms of cost-effectiveness, current screening practice remained inefficient in all simulations conducted, implying that although guidelines-based strategies are more costly, the gains in health are also relatively greater. The added health benefit of improving compliance with guidelines, especially the 3-year interval for cytologic screening and diagnostic follow-up, may justify additional investments in interventions to improve U.S. cervical cancer screening practice.

Note: For an embargoed PDF, please Cara Graeff. The lead author, Dr. Jane Kim, can be reached through Todd Datz at or 617-432-8413.

3. Two evidence reviews assess behavioral interventions for type 1 and type 2 diabetes

According to two systematic evidence reviews published in Annals of Internal Medicine, behavioral interventions offer limited improvements in glycemic control for patients with type 1 and type 2 diabetes. Such interventions did not seem to affect other health outcomes.

Type 1 diabetes

Type 1 diabetes is one of the most common chronic diseases in childhood and adolescents and is increasing in prevalence in the U.S. Intensive glycemic control has been proven to prevent diabetes-related health complications and death. Other factors, such as intensive lowering of blood pressure and diabetes-related stress management seem to improve outcomes, as well. Some data suggest that behavioral approaches for self-management programs benefit individuals with type 1 diabetes.

Researchers conducted a systematic review and meta-analysis of published research to determine the effects of behavioral programs for patients with type 1 diabetes on behavioral, clinical, and health outcomes and to investigate factors that might moderate the effect of such programs. They found that behavioral programs for type 1 diabetes offer some benefit for glycemic control, at least at short-term follow-up. The current evidence does not support encouraging patients with type 1 diabetes to participate in behavioral programs to improve outcomes except for glycemic control.

Type 2 diabetes

More than 29 million Americans suffer from type 2 diabetes. Tight glycemic control is important for reducing microvascular complications, as is management of body weight, blood pressure, and cholesterol levels. As such, patients with type 2 diabetes are advised to adhere to multiple self-care behaviors, including healthy eating, being active, taking medications, and healthy coping. Evidence suggests that behavioral interventions can help patients stick to their programs and achieve better health outcomes.

Researchers reviewed published evidence to identify factors that could improve the effectiveness of behavioral programs for adults with type 2 diabetes. They found that more intensive programs were more effective and worked better for patients with suboptimal glycemic control than for those with good control. Self-management education programs with 10 or fewer hours of contact with delivery personnel provided little benefit.

Note: For an embargoed PDF, please contact Angela Collom. The lead author of both reviews, Ms. Jennifer Pillay, can be reached through Michael Brown at or 780-492-9407.
Also in this issue:

Right-to-Try Laws: Hope, Hype, and Unintended Consequences
Alison Bateman-House, PhD, MPH, MA; Laura Kimberly, MSW, MBE; Barbara Redman, PhD, MBE; Nancy Dubler, LLB; and Arthur Caplan, PhD

Ideas and Opinions

Content, Consistency, and Quality of Black Box Warnings: Time for a Change
Tarig Elraiyah, MBBS, MSc; Michael R. Gionfriddo, PharmD; Victor M. Montori, MD, MSc; and Mohammad Hassan Murad, MD, MPH

Ideas and Opinions

American College of Physicians

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.